MRK

Merck News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Merck and Co Inc MRK NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
1,15 1,26% 92,32 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
91,26 90,385 92,49 92,42 91,17
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.6.202213:00BWMerck Announces the Launch of the Merck Digital Sciences..
29.6.202212:45BWMerck to Hold Second-Quarter 2022 Sales and Earnings..
27.6.202214:37TRMNCowen & Co. Keeps Their Hold Rating on Merck & Company (MRK)
27.6.202212:45BWLYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP..
24.6.202213:29DJNMerck Gets EU Approval of Expanded Keytruda Use in Melanoma
24.6.202212:45BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) as..
23.6.202200:28BWCDC’s ACIP Unanimously Votes to Provisionally Recommend Use..
22.6.202213:27DJNMerck: FDA Approves Vaxneuvance Vaccine in Infants, Children
22.6.202212:45BWU.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal..
21.6.202222:30BWResults From Phase 3 PROpel Trial of LYNPARZA® (olaparib)..
21.6.202222:10BWMerck Announces that Chirfi Guindo will Lead Marketing for..
21.6.202215:45TRMNMizuho Securities Sticks to Their Buy Rating for Merck &..
21.6.202213:56DJNMerck Reports Positive Phase 1/2 Study Results for V116..
21.6.202212:45BWMerck Presents Positive Results from Phase 1/2 Study..
20.6.202209:33TRMNWill Merck acquire Seagen?
17.6.202217:06DJNSeagen Shares Rally After WSJ Reports Merck Mulling a Deal
15.6.202220:22EDGARAnnual Report of Employee Stock Plans (11-k)
15.6.202220:20EDGARAnnual Report of Employee Stock Plans (11-k)
15.6.202220:07EDGARAnnual Report of Employee Stock Plans (11-k)
13.6.202214:08DJNMerck Seeks FDA's OK to Use Keytruda as Adjuvant Lung Cancer..
13.6.202212:45BWFDA Accepts Application for Merck’s KEYTRUDA®..
08.6.202212:51BWMerck to Participate in the 2022 Goldman Sachs 43rd Annual..
08.6.202204:15TRMNMizuho Securities Maintains Their Buy Rating on Merck &..
07.6.202212:45BWMerck and Ridgeback Announce New Data For Investigational..
07.6.202212:30BWMerck to Hold Investor Event to Highlight Oncology Portfolio..
06.6.202209:08DJNNetScientific Says FDA Granted PDS0101 Cancer Treatment Fast..
05.6.202214:00BWAdjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab)..
01.6.202222:28EDGARStatement of Changes in Beneficial Ownership (4)
01.6.202222:26EDGARStatement of Changes in Beneficial Ownership (4)
01.6.202222:23EDGARStatement of Changes in Beneficial Ownership (4)
01.6.202222:20EDGARStatement of Changes in Beneficial Ownership (4)
01.6.202222:16EDGARStatement of Changes in Beneficial Ownership (4)
01.6.202222:08EDGARInitial Statement of Beneficial Ownership (3)
24.5.202219:46BWMerck Announces Third-Quarter 2022 Dividend
24.5.202213:30DJNMerck Gets EU Approval of Expanded Keytruda Use in Breast..
24.5.202212:45BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus..
20.5.202215:11DJNMerck Gets CHMP Backing for Expanded Keytruda Use in..
20.5.202214:15BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
19.5.202204:06TRMNBerenberg Bank Maintains a Hold Rating on Merck & Company..
13.5.202220:33EDGARNotice of Exempt Solicitation. Definitive Material...
10.5.202212:45BWMerck To Present Data at 2022 ASCO Annual Meeting..
05.5.202223:47EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:39EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:32EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:32EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:28EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:27EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:26EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:20EDGARStatement of Changes in Beneficial Ownership (4)
05.5.202223:16EDGARStatement of Changes in Beneficial Ownership (4)
Kürzlich von Ihnen besucht
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20220703 17:25:45